Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3068808 | 0.91 | ALDH1A1 (0.34) | SPHK1MEN1CYP3A4KMT2AOPRM1 | |
| SCHEMBL19394028 | 0.78 | MEN1 (0.32) | MEN1CYP3A4KMT2AOPRM1FDPS | |
| SCHEMBL9198238 | 0.77 | CA1 (0.50) | SPHK1LMNAMEN1CYP3A4KMT2A | |
| SCHEMBL11973104 | 0.77 | CA1 (0.50) | SPHK1LMNAMEN1CYP3A4KMT2A | |
| SCHEMBL6037327 | 0.77 | CA1 (0.50) | SPHK1LMNAMEN1CYP3A4KMT2A | |
| SCHEMBL11227926 | 0.77 | CA1 (0.50) | SPHK1LMNAMEN1CYP3A4KMT2A | |
| SCHEMBL1782449 | 0.76 | CA1 (0.48) | OPRM1SMPD1ACE2GPR84FDPS | |
| SCHEMBL13858988 | 0.75 | OPRM1 (0.55) | SPHK1LMNAOPRM1SMPD1TSHR | |
| SCHEMBL11486416 | 0.75 | OPRM1 (0.55) | SPHK1LMNAOPRM1SMPD1TSHR | |
| SCHEMBL325629 | 0.75 | OPRM1 (0.55) | SPHK1LMNAOPRM1SMPD1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2678410-B1 | COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | PROCTER & GAMBLE (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9193937-B2 | Mixtures of C10-C13 alkylphenyl sulfonates | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2012138423-A1 | COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | THE PROCTER & GAMBLE COMPANY | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | SMURF1, C1S, SMURF2 | SPHK1 766/4885LMNA 3546/4885MEN1 2731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.